Release Date: 19/05/16 14:52 Summary: Final Director's Interest Notice - Appendix 3Z-PSA.AX Price Sensitive: No Download Document 63.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%